ACN - 101321555 Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

Resource Library

Research Ethics MonthlyAbout Us

ResourcesMedical research

Australasian Human Research Ethics Consultancy Services Pty Ltd (AHRECS)

More detailed guidance on the inclusion/exclusion of retracted articles in systematic reviews is needed (Papers: July 2019)0

Posted by Admin in on August 20, 2019
 

A forced retraction will generally (but not always) point to something seriously wrong with a research output/project, so it is essential they don’t result in a distortion of knowledge and practice. This recent journal paper suggests a sensible approach.

There are currently no clear guidelines on how to proceed when a retracted article is selected in the systematic review process. The Cochrane handbook provides information only on how to identify retracted articles within the scientific literature, instead of clear guidance and criteria for inclusion in the systematic review or not [1]. Other guidelines for conducting systematic reviews do not address this topic [2,3]. Common sense would indicate the exclusion from a systematic review of a study that was retracted because of faked or unreliable data [4].
.

Faggion, C. M., Jr. “More detailed guidance on the inclusion/exclusion of retracted articles in systematic reviews is needed.” Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2019.07.006
Publisher: https://www.jclinepi.com/article/S0895-4356(19)30573-6/abstract

(US) NIH probe of foreign ties has led to undisclosed firings-and refunds from institutions – Science (Jeffrey Mervis | June 2019)0

Posted by Admin in on August 17, 2019
 

An aggressive effort by the National Institutes of Health (NIH) to enforce rules requiring its grantees to report foreign ties is still gathering steam. But it has already had a major impact on the U.S. biomedical research community. A senior NIH official tells ScienceInsider that universities have fired more scientists—and refunded more grant money—as a result of the effort than has been publicly known.

Since August 2018, Bethesda, Maryland–based NIH has sent roughly 180 letters to more than 60 U.S. institutions about individual scientists it believes have broken NIH rules requiring full disclosure of all sources of research funding. To date, the investigation has led to the well-publicized dismissals of five researchers, all Asian Americans, at MD Anderson Cancer Center in Houston, Texas, and Emory University in Atlanta.

But other major U.S. research universities have also fired faculty in cases that have remained confidential, according to Michael Lauer, head of NIH’s extramural research program. And some have repaid NIH “hundreds of thousands of dollars” in grants as a result of rule violations, he says. “I can understand why [the universities] aren’t talking about it,” Lauer says. “No organization wants to discuss personnel actions in a public forum.”

Read the rest of this discussion piece

AMWA–EMWA–ISMPP joint position statement on predatory publishing (Papers: American Medical Writers Association, et al | July 2019)0

Posted by Admin in on August 12, 2019
 

The American Medical Writers Association (AMWA), the European Medical Writers Association (EMWA) and the International Society for Medical Publication Professionals (ISMPP) recognize the challenges to scientific publishing being posed by predatory journals and their publishers, which employ practices undermining the quality, integrity and reliability of published scientific research. This joint position statement complements several other sets of guidelines that have helped define the characteristics of a predatory journal1–

American Medical Writers Association, European Medical Writers Association & International Society for Medical Publication Professionals (2019) AMWA–EMWA–ISMPP joint position statement on predatory publishing,Current Medical Research and Opinion,35:9, 1657-1658,10.1080/03007995.2019.1646535
Publisher (Open Access): https://www.tandfonline.com/doi/full/10.1080/03007995.2019.1646535

China approves ethics advisory group after CRISPR-babies scandal – Nature (Hepeng Jia | August 2019)0

Posted by Admin in on August 10, 2019
 

Bioethicists hope a national committee will help close loopholes in the country’s biomedical ethics regulations.

China will establish a national committee to advise the government on research-ethics regulations. The decision comes less than a year after a Chinese scientist sparked an international outcry over claims that he had created the world’s first genome-edited babies.

The country’s most powerful policymaking body, the Central Comprehensively Deepening Reforms Commission of the ruling Chinese Communist Party, headed by President Xi Jinping, approved at the end of last month a plan to form the committee. According to Chinese media, it will strengthen the coordination and implementation of a comprehensive and consistent system of ethics governance for science and technology.

The government has released few details on how the committee will work. But Qiu Renzong, a bioethicist at the Chinese Academy of Social Science in Beijing, says it could help to reduce the fragmentation in biomedical ethics regulations across ministries, identifying loopholes in the enforcement of regulations and advise the government on appropriate punishments for those who violate the rules.

Read the rest of this news story

0